banner

Latest News

Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)

From Business Wire –  CIVILIZATION VENTURES ANNOUNCES PORTFOLIO EXIT WITH ACQUISITION OF SINGULAR BIO BY INVITAE (NYSE: NVTA) Singular Bio, Inc. (“Singular Bio”) is a privately held company developing single molecule detection technology to enable lower costs and expanded use of high-quality, cell-free DNA analysis, initially for application in non-invasive prenatal screening (NIPS).Invita...

Read More

Prenatal Testing Firm BillionToOne Closes $15M Series A Financing

From Genome Web –  NEW YORK (GenomeWeb) – BillionToOne, a Bay Area startup developing a molecular counting technology for noninvasive prenatal testing, said today that is has closed an oversubscribed $15 million Series A financing round. Hummingbird Ventures and NeoTribe Ventures led the investment round, with participation from Y Combinator, Civilization Ventures, Fifty Years, 500 ...

Read More

Prellis Biologics raises $9m

From Mass Device –  Prellis Biologics has raised $8.7 million in a new round of equity financing, according to a recently posed SEC filing. The San Francisco-based company is developing ultra-fast high-resolution holographic laser printing technology intended for use in creating human organs and tissues, according to its website. Prellis Biologics offers a number of products b...

Read More

Wild Earth Reels in $550,000 from Mark Cuban in 'Shark Tank'

From PR Newswire –  BERKELEY, Calif., March 18, 2019 /PRNewswire/ -- Wild Earth, Inc., a startup reinventing pet food with biotech, today announced it has accepted an investment of $550,000 from serial entrepreneur, investor, and owner of the Dallas Mavericks Mark Cuban on the ABC hit "Shark Tank." The episode premiered last night and is available on demand at&nbs...

Read More

uLab Aligner Treatment Planning Software Reaches Significant Milestone

From Orthodontic Products Online: uLab Aligner Treatment Planning Software Reaches Significant Milestone –  uLab Systems, Redwood City, Calif, the creator of an orthodontic aligner movement planning software, announced that it has passed a significant commercial milestone with over 6,000 cases completed in just 6 months. uLab launched its pilot program with a select group of or...

Read More

Will This New Robot That Helps You Take Pills Have a Better Fate Than Jibo?

From BostInno: Will This New Robot That Helps You Take Pills Have a Better Fate Than Jibo?  “Pillo, tell me about yourself,” Emanuele Musini, CEO of Boston-based robotics startup Pillo Health, orders. It’s a bright Monday afternoon, and the three of us—myself, serial entrepreneur Musini and, well, Pillo The Robot—are chatting in a meeting room at WeWork on Melcher Street. M...

Read More

What do Bollywood and Rocket Pharma have in common? Possibly a Grammy.

Rocket Pharma  – Gaurav Shah, CEO of Rocket Pharmaceuticals, is a man of many talents. In his spare time, he joins his wife, Falguni Shah, on stage to perform her music in Hindi, English, and Gujarati under the stage name of Falu. Gaurav is featured on her most recent album, Falu's Bazaar, which was recently nominated for a Grammy.  Falu composes her own music and lyric...

Read More

Civilization Ventures: Holiday Event to Celebrate Women in Science

Celebrating Women Leaders in Healthcare –   Civilization Ventures and First Republic Bank’s Tech and Venture Team hosted a holiday event celebrating female founders' unique opportunities and challenges. An investor and founder panel was followed by cocktails and appetizers. The audience is a co-ed group of founders and investors. Linda AveyPrecise.ly, Co-founder and CEO; 23andMe, Co-fou...

Read More

Prellis Biologics, Inc. Announces Vascular Tissue Blanks™, a Series of Ready to Use, Pre-Vascularized Tissue Scaffolds for Complex 3D Cell and Tissue Cultures and Transplantation

From Business Wire –  Tissue engineering company Prellis Biologics launched the first ever line of pre-vascularized 3D (three-dimensional) tissue scaffolds today. The scaffolds are biocompatible and can be used by researchers to grow any cell type in 3D formats 1000x larger than 3D spheroids. For the first time, therapeutics can be tested on accurate, easily replicated, fas...

Read More

BioPrinting with Alzheimer’s Stem Cells May Lead to Improved Drug Testing & Treatment

From 3DPrint.com: BioPrinting with Alzheimer’s Stem Cells May Lead to Improved Drug Testing & Treatment –  Alzheimer’s studies give many of us hope, whether we have a relative or friend suffering from the dreaded disease—or simply because we are hoping that a cure will be there if we begin to experience symptoms of the most common and crushing form of dementia. As bioprinting bec...

Read More